Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

177
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
267.4 254 255.5 271.4 268.7 Last
2412468 8994195 6233050 7989629 5170971 Volume
+0.11% -5.01% +0.59% +6.22% -0.99% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
10/30Earnings Release
Surperformance© rating of Novo Nordisk A/S
Trading Rating : Investor Rating :
More about the company
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2014 88 435 M
EBIT 2014 33 844 M
Net income 2014 26 378 M
Finance 2014 7 225 M
Yield 2014 1,76%
Sales 2015 97 699 M
EBIT 2015 38 690 M
Net income 2015 29 550 M
Finance 2015 8 266 M
Yield 2015 2,03%
PER 2014 26,80
PER 2015 23,30
EV / Sales 2014 6,34x
EV / Sales 2015 5,73x
Capitalization 567 646 M
More Financials
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
1d ago Novo Nordisk A/S - Trading in Novo Nordisk shares by board members, executive..
1d agoDJNOVO NORDISK A/S : Spends DKK750 Million on New Diabetes Resarch Lab
1d ago NOVO NORDISK A/S : invests DKK 750 million in new laboratories for diabetes rese..
2d agoDJEUROPE MARKETS : European Stocks Climb For Third Straight Day
2d agoDJEUROPE MARKETS : European Stocks Fall For First Time In Three Days
2d ago NOVO NORDISK A/S : now hiring for new manufacturing facility in New Hampshire
2d agoDJEUROPE MARKETS : European Stocks Falls For First Time In Three Days
2d ago Novo Nordisk increased operating profit in local currencies by 11% in the fir..
3d ago NOVO NORDISK A/S : Patent Issued for Pharmaceutical Solution of Non Covalently B..
3d ago NOVO NORDISK A/S : Investigators from Novo Nordisk Zero in on Diabetes (Clinical..
3d ago NOVO NORDISK A/S : Diabetes Education Program Receives NCQA Disease Management C..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF